New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers

Jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

This webcast is jointly provided by A. Webb Roberts Center for CME of Baylor Health Care System and CancerNet.

Release date: November 18, 2015

Valid through: November 18, 2016

Specialty: Hematology/Oncology

Topic: CLC, Head & Neck and Thyroid Cancer

Target Audience:

This symposium is directed primarily to hematologists/oncologists, radiation oncologists, researchers, pharmacists, registered nurses, physician assistants, nurse practitioners and fellows in training interested in new development in lung cancer, head & neck cancer and thyroid cancer. No specific skill or knowledge other than a basic training in hematology/oncology is required for successful participation in this activity.

Program Overview:

This symposium is intended to improve care of patients with lung cancer, head & neck cancer and thyroid cancer by accelerating adoption of new guidelines and evidence-based practice change. The format will include didactic lectures from known opinion leaders, question and answer sessions, and ample opportunity for participant interaction with faculty.

This program consists of 4 continuing education activities.

Click the links below to review the activity launch pages containing full disclosure information.

Module 1 — New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers — 1.75 AMA PRA Category 1 Credits™

Module 2 — New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers — 1.5 AMA PRA Category 1 Credits™

Module 3 — New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers — 1.0 AMA PRA Category 1 Credits™

Module 4 — New Paradigms in the Treatment of Non-Small-Cell Lung Cancer, Head & Neck and Thyroid Cancers — 1.0 AMA PRA Category 1 Credits™